Stepchenko, A.G.; Georgieva, S.G.; Pankratova, E.V.
XMU-MP-1, Inhibitor of STE20-like MST1/2 Kinases of the Hippo Signaling Pathway, Suppresses the Cell Cycle, Activates Apoptosis and Autophagy, and Induces Death of Hematopoietic Tumor Cells. Pharmaceuticals 2025, 18, 874.
https://doi.org/10.3390/ph18060874
AMA Style
Stepchenko AG, Georgieva SG, Pankratova EV.
XMU-MP-1, Inhibitor of STE20-like MST1/2 Kinases of the Hippo Signaling Pathway, Suppresses the Cell Cycle, Activates Apoptosis and Autophagy, and Induces Death of Hematopoietic Tumor Cells. Pharmaceuticals. 2025; 18(6):874.
https://doi.org/10.3390/ph18060874
Chicago/Turabian Style
Stepchenko, Alexander G., Sofia G. Georgieva, and Elizaveta V. Pankratova.
2025. "XMU-MP-1, Inhibitor of STE20-like MST1/2 Kinases of the Hippo Signaling Pathway, Suppresses the Cell Cycle, Activates Apoptosis and Autophagy, and Induces Death of Hematopoietic Tumor Cells" Pharmaceuticals 18, no. 6: 874.
https://doi.org/10.3390/ph18060874
APA Style
Stepchenko, A. G., Georgieva, S. G., & Pankratova, E. V.
(2025). XMU-MP-1, Inhibitor of STE20-like MST1/2 Kinases of the Hippo Signaling Pathway, Suppresses the Cell Cycle, Activates Apoptosis and Autophagy, and Induces Death of Hematopoietic Tumor Cells. Pharmaceuticals, 18(6), 874.
https://doi.org/10.3390/ph18060874
